Institut Biochimique SA
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Institut Biochimique SA
With three additional commercial launches lined up for 2023, Yaral has opted to expand its pre-existing partnership with life sciences service provider Eversana to support these activities.
Start-ups raised $1.8 billion in Q1 2016. Biopharma companies penned 33 alliances; 14 acquisitions were signed (11 in the biopharma industry).
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced January-February 2016.
Even with recent letters, Office of Prescription Drug Promotion’s slow pace continues from 2014’s record low.
- Medical Devices
- Drug Delivery
- Other Names / Subsidiaries
- AMSA Italy
- Gelfipharma Italy
- IBSA Italy
- IBSA Pharma Hungary
- IBSA Slovakia
- Laboratoires Genevrier France
- Rizhao Lanshan China
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.